John M. Maris, MD

For paramount pediatric cancer research resulting in the discovery of the genetic basis of neuroblastoma, elucidation of its molecular pathogenesis, development of novel methods for immunotherapy target discovery, and establishment of anti-tumor peptide-centric chimeric antigen receptors across multiple human leukocyte antigen alleles in neuroblastoma and other childhood cancers, overcoming the challenge of targeting intracellular proteins.

*Full-length biography pending